These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 30684075

  • 1. Early Postoperative Anti-TNF Therapy Does Not Increase Complications Following Abdominal Surgery in Crohn's Disease.
    Schad CA, Haac BE, Cross RK, Syed A, Lonsako S, Bafford AC.
    Dig Dis Sci; 2019 Jul; 64(7):1959-1966. PubMed ID: 30684075
    [Abstract] [Full Text] [Related]

  • 2. Are Biologics Safe in the Immediate Postoperative Period? A Single-Center Evaluation of Consecutive Crohn's Surgical Patients.
    Lightner AL, Grass F, Alsughayer AM, Harmsen WS, Petersen M, Loftus EV.
    Dis Colon Rectum; 2020 Jul; 63(7):934-943. PubMed ID: 32149787
    [Abstract] [Full Text] [Related]

  • 3. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients.
    Lightner AL, McKenna NP, Alsughayer A, Loftus EV, Raffals LE, Faubion WA, Moir C.
    J Pediatr Surg; 2019 Oct; 54(10):2162-2165. PubMed ID: 30773391
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
    Syed A, Cross RK, Flasar MH.
    Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
    [Abstract] [Full Text] [Related]

  • 6. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease.
    Nasir BS, Dozois EJ, Cima RR, Pemberton JH, Wolff BG, Sandborn WJ, Loftus EV, Larson DW.
    J Gastrointest Surg; 2010 Dec; 14(12):1859-65; discussion 1865-6. PubMed ID: 20872084
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
    Rodríguez-Lago I, Hoyo JD, Pérez-Girbés A, Garrido-Marín A, Casanova MJ, Chaparro M, Fernández-Clotet A, Castro-Poceiro J, García MJ, Sánchez S, Ferreiro-Iglesias R, Bastón I, Piqueras M, Careda LEIB, Mena R, Suárez C, Cordón JP, López-García A, Márquez L, Arroyo M, Alfambra E, Sierra M, Cano N, Delgado-Guillena P, Morales-Alvarado V, Aparicio JC, Guerra I, Aulló C, Merino O, Arranz L, Hidalgo MA, Llaó J, Plaza R, Molina G, Torres P, Pérez-Galindo P, Romero MG, Herrera-deGuise C, Armesto E, Mesonero F, Frago-Larramona S, Benítez JM, Calvo M, Martín MDCL, Elorza A, Larena A, Peña E, Rodríguez-Grau MDC, Miguel-Criado J, Botella B, Olmos JA, López L, Aguirre U, Gisbert JP, Young GETECCU Group.
    United European Gastroenterol J; 2020 Nov; 8(9):1056-1066. PubMed ID: 32723069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early Anti-Tumor-Necrosis-Factor Therapy for Crohn's Disease-Related Abdominal Abscesses and Phlegmon in Children.
    Constant BD, de Zoeten EF, Weinman JP, Albenberg L, Scott FI.
    Dig Dis Sci; 2023 Mar; 68(3):877-888. PubMed ID: 35790702
    [Abstract] [Full Text] [Related]

  • 12. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease.
    Lightner AL, Raffals LE, Mathis KL, Cima RR, Tse CS, Pemberton JH, Dozois EJ, Loftus EV.
    J Crohns Colitis; 2017 Feb; 11(2):185-190. PubMed ID: 27543504
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn's Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients.
    Jouvin I, Lefevre JH, Creavin B, Pitel S, Chafai N, Tiret E, Beaugerie L, Parc Y, Saint-Antoine IBD Network.
    Inflamm Bowel Dis; 2018 Jan 18; 24(2):422-432. PubMed ID: 29361093
    [Abstract] [Full Text] [Related]

  • 17. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
    Yu CS, Jung SW, Lee JL, Lim SB, Park IJ, Yoon YS, Kim CW, Yang SK, Ye BD, Park SH, Han M, Kim JC.
    Inflamm Bowel Dis; 2019 Aug 20; 25(9):1559-1568. PubMed ID: 30753560
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of medical therapy on patients with Crohn's disease requiring surgical resection.
    Fu YT, Hong T, Round A, Bressler B.
    World J Gastroenterol; 2014 Sep 07; 20(33):11808-14. PubMed ID: 25206286
    [Abstract] [Full Text] [Related]

  • 20. Readmission After Abdominal Surgery for Crohn's Disease: Identification of High-Risk Patients.
    Mege D, Michelassi F.
    J Gastrointest Surg; 2018 Sep 07; 22(9):1585-1592. PubMed ID: 29770917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.